Dailypharm Live Search Close

New drug pre-registration - post-evaluation non-face-to-face

By Lee, Jeong-Hwan | translator Kim, Jung-Ju

23.06.20 05:50:52

°¡³ª´Ù¶ó 0
Ho-Jun Son, Manager, ¡°I will put my concerns about new drugs and medical technologies, and an innovative health insurance system¡±



The government plans to include discussions on the need to apply innovative insurance systems such as new drugs and new medical technology 'seondeungjae-postevaluation' to strengthen treatment coverage for severe diseases such as cancer in the '2nd National Health Insurance Comprehensive Plan' to be established in the second half of this year. The purpose is to draw a blueprint for the future in which a sustainable health insurance policy to supply new drugs and new medical technologies to the people in a timely manner can be discussed at the social consensus body.

In particular, it also revealed the direction that measures to activate home medical treatment and institutionalize non-face-to-face treatme

Lee, Jeong-Hwan(junghwanss@dailypharm.com)
If you want to see the full article, please JOIN US (click)